(Q54388604)
Statements
In vivo effects of recombinant IL-2. I. Isolation of circulating Leu-19+ lymphokine-activated killer effector cells from cancer patients receiving recombinant IL-2. (English)
McMannis JD
Fisher RI
Creekmore SP
Braun DP
Harris JE
Ellis TM
1 February 1988
140
4
1335-1340